Perioperative anesthetic management in morbidly obese patients

S. L. Epshtein

Regional Anesthesia and Acute Pain Management ›› 2012, Vol. 6 ›› Issue (3) : 5 -27.

PDF
Regional Anesthesia and Acute Pain Management ›› 2012, Vol. 6 ›› Issue (3) : 5 -27. DOI: 10.17816/RA36128
Articles
review-article

Perioperative anesthetic management in morbidly obese patients

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
S. L. Epshtein. Perioperative anesthetic management in morbidly obese patients. Regional Anesthesia and Acute Pain Management, 2012, 6(3): 5-27 DOI:10.17816/RA36128

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Бунятян А.А., Мещеряков А.В., Цибуляк В.Н. Атаралгезия. 1983. 172 с.

[2]

Горобец E.С. Побуждающая спирометрия - оптимальный метод послеоперационной профилактики ателектазов // Вестник интенсивной терапии. 1997. № 1-2. С. 65-69.

[3]

Горобец Е.С. Принципы анестезии при абдоминальных онкологических операциях // Вестник интенсивной терапии. 2008. № 2. С. 18-25.

[4]

Инструкция по медицинскому применению препарата БРАЙДАН. Регистрационный номер: ЛСР-003970/10.

[5]

Кальви Т., Уильямс Н. Фармакология для анестезиолога. М., 2007. 180 с.

[6]

Роузен М., Латто Я., Шенг Нг У. Чрескожная катетеризация центральных вен.М.: Медицина, 1986. 160 с.

[7]

Ферранте М., ВейдБонкор Т. Послеоперационная боль. Медицина, 1998.

[8]

Эпштейн С.Л. и др. Периоперационное анестезиологическое обеспечение больных с морбидным ожирением при операциях билиопанкреатического шунтирования // Вестник интенсивной терапии. 2008. № 3. С. 69-73; № 4. С. 31-36.

[9]

Эпштейн С.Л. и др. Трансдермальные терапевтические системы ТРАНСТЕК и ДЮРОГЕЗИК как средства послеоперационного обезболивания в радикальной хирургии морбидного ожирения // Регионарная анестезия и лечение острой боли. 2010.Т. IY, № 2. С. 13-24.

[10]

Adams J., Muphy P. Obesity in anaesthesia and intensive care // Br. J. Anaesth. 2000; 85(1): 91-108.

[11]

Agarwal R. et al. Venous thromboembolism prophilaxis for patients undergoing bariatric surgery: a systematic review // Surg. Obes. Relat. Dis. 2010; 6: 213-220.

[12]

Akbay B., Hayit F., Pehlivan M., Agartan C. Anaesthetic management of an extremely obese woman undergoing open gastric bypass // Eur. J. Anaesth. 2006; 23(11): 983-986.

[13]

Aldencortt M. et al. Ventilation strategies in obese patients undergoing surgery: systematic review and meta-analysis // Euroanaesthesia. 2011; Amsterdam, 5AP1-3.

[14]

Bathory J. et al. Evaluation of the video intubation in morbid obese patients // Acta Anaesth. Scand. 2010; 54: 55-58.

[15]

Bellamy M., Struys M. Anaesthesia for the overweight and obese patient // Oxford University Press, 2007; 108.

[16]

Biring M.S., Lewis M.I., Liu J.I., Mohsenifar Z. Pulmonary physiologic changes of morbid obesity // Am. J. Med. Sci. 1999; 318: 293-297.

[17]

Bostanjian D., Anthone G., Hamoui N. Rhabdomyolysis of gluteal muscles leading to renal failure: a potentially fatal complication of surgery in the morbidly obese // Obes. Surg. 2003; 13: 302-305.

[18]

Brodsky J., Lemmens H. Regional anesthesia and obesity // Obes. Surg. 2007; 17: 1146-1149.

[19]

Brodsky J., Lemmens H. Anesthetic management of the obese surgical patient // Cambridge, 2012; 137 p.

[20]

Carmody B. et al. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institutions 24-year experience // J. Am. Coll. Surg. 2006; 203: 831-837.

[21]

Casati A., Putzu M. Anaesthesia in the obese patient: pharmacokinetic considerations // J. Clin. Anesth. 2005; 17: 134145.

[22]

Conor J. et al. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery // Surg. Obes. Rel. Dis. 2010; 6: 322-325.

[23]

Criddle L. Rhabdomyolysis. Pathophysiology, recognition and management // Crit. Care Nurs. 2003; 23: 14-22.

[24]

Derry C. et al. Pharmcokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men // J. Clin. Psychopharmacol. 1995; 15: 197-205.

[25]

Dindo D. et al. Obesity in general elective surgery // Lancet. 2003; 361: 2032-2035.

[26]

Douglas N., Polo O. Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome // Lancet. 1994; 344: 653-655.

[27]

Ettinger J., Marcilio C., Santos-Filho P. et al. Rhabdomyolysis: diagnosis and treatment in bariatric surgery // Obes. Surg. 2007; 17: 525-532.

[28]

Flum D. et al. Perioperative safety in the longitudinal assessment of bariatric surgery // N. Engl. J. Med. 2000; 361: 445454.

[29]

Gonzaga C.C., Calhoun D.A. Resistant hypertension and hyperaldosteronism // Curr. Hypertens. Rep. 2008; 10: 496-503.

[30]

Gonzalez H. et al. The importence of increased neck circumference to intubation difficultes in obese patients // Anesth. Analg. 2008; 106: 1132-1136.

[31]

Greenblatt D. et al. Effect of age, gender, and obesity on midazolam kinetics // Anesthesiology. 1984; 61: 27-35.

[32]

Greyson C. Pathophysiology of right ventricular failure // Crit. Care Med. 2008; 36(1 suppl): S57-65.

[33]

Harter R. et al. A comparison of the volume and pH of gastric contents of obese and lean surgical patients // Anesth. Analg. 1998; 86: 147-152.

[34]

Heller A. Optimizing clinical pathways using regional anaesthesia. Refresher course lectures. Madrid, Euroanaesthesia, 3-6 june 2006; 1-6.

[35]

Helling T., Willoughby T., Maxfield D., Ryan P. Determinants of the need for intensive care and prolonged mechanical ventilation in patients undergoing bariatric surgery // Obes. Surg. 2004; 14: 1036-1041.

[36]

Hodgkinson R., Husain E. Obesity and the cephalad spread of analgesia following epidural administration of bupivacaine for Cesarean section // Anesth. Analg. 1980; 59: 89-92.

[37]

Hogue C. et al. The impact of obesity on outcomes after critical illness: a meta-analysis // Intensive Care Med. 2009; 35: 1152-1170.

[38]

Kehlet H. Fast-track surgery-the role of anaesthesiologist and perioperative pain management. Refresher course lectures // Munich. 2007; 153-155.

[39]

Kessler R. et al. Pulmonary hypertension in obstructive sleep apnea syndrome: prevalence, cause and therapeutic cosequences // Eur. Respir. J. 1996; 35: 787-794.

[40]

Lambert D., Marceau S., Forse R. Intra-abdominal pressure in the morbidly obese // Obes. Surg. 2005; 15: 1225-1232.

[41]

Lemmens H., Bernstein D., Brodsky J. Estimating blood volume in obese and morbidly obese patients // Obes. Surg. 2006; 16: 773-776.

[42]

Llanrado S. et al. Dose of sugammadex adjusted to level of neuromuscular blockade in morbid obese patients scheduled for bariatric surgery. Euroanaesthesia, 2011, Amsterdam, 9AP3-7.

[43]

Maltby J. et al. Drinking 300 ml of clear fluid two hours before surgery has no effect on gastric fluid volume and pH in fasting and non-fasting obese patients // Can. Anaesth. 2004; 51: 111-115.

[44]

Matthay M. et al. Ventilator-induced lung injury: in vivo and in vitro mechanisms // Am. J. Phusiol. Lung. Cell. Mol. Phisiol. 2002; 283: L678-682.

[45]

Meng L. Postoperative nausea and vomiting with application of postoperative continuous positive airway pressure after laparoscopic gastric bypass // Obes. Surg. 2010; 20: 876-880.

[46]

Morbid Obesity.A. Alvares, J. Brodsky, H. Lemmens, J. Morton. Cambridge, 2010. 246 p.

[47]

Morino M. et al. Mortality after bariatric surgery: analysis of 13871 morbidly obese patients from a national registry // Ann. Surg. 2007; 246: 1002-1007.

[48]

Mulier J.P. A retrospective analysis of the intraduction of sugammadex on the incidence of respiratory failure after bariatric surgery // Obesity Surgery. 2011; 21(8): 1051.

[49]

Naropin. Монография. 1999. 200 с.

[50]

Nazar C. et al. Dexamethasone for posoperative nausea and vomiting prophylaxis: effect on glycaemia in obese patients with impaired glucose tolerance // Eur. J. Anaesthesiol. 2009; 26: 318-321.

[51]

Nielsen K., Guller U., Susan M. et al. Influence of obesity on surgical regional anesthesia in the ambulatory setting: an analysis 0f 9038 blocks // Anesthesiology. 2005; 102: 181-187.

[52]

Niemi G., Bravik H. Epinephrine markedly improves thoracic epidural analgesia produced by small-dose infusion of ropivacaine, fentanyl, and epinephrine after major thoracic or abdominal surgery: a randomized double-blinded crossover study with and without epinephrine // Anesth. Analg. 2002; 94: 1598-1605.

[53]

Pandazi A., Bourliotti A., Kostopanagiotou G. Bispectral index (BIS) monitoring in morbidly obese patients undergoing gastric bypass surgery: experience in 23 patients // Obes. Surg. 2005; 15: 58-62.

[54]

Panni M., Columb M. Obese parturients have lower epidural local anaesthetic requirements for analgesia in labour // Br. J. Anaesth. 2006; 96: 106-110.

[55]

Panni M.K., Columb M.O. Obese parturients have love epidural local anaesthetic requirements for analgesia in labour // Br. J. Anaesth. 2006 Jan; 96(1): 106-110.

[56]

Pelosi P. et al. The effect of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia // Anesth. Analg. 1998; 87: 645-660.

[57]

Pelosi P. et al. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients // Chest. 1996; 109: 155-151.

[58]

Puhringer F. et al. Pharmacokinetics of rocuronium bromide in obese female paitients // Eur. J. Anaesthesiol. 1999; 16: 507-510.

[59]

Rocha A. et al. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery // Obes. Surg. 2006 Dec; 16(12): 1645-1655.

[60]

Sapala J. et al. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis // Obes. Surg. 2003; 13: 819-825.

[61]

Schein M., Wittmann D., Aprahamian C. The abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure // J. Am. Coll. Surg. 1995; 180: 745-753.

[62]

Schindler C. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? Ther. Adv. Cardivasc. Dis. 2007; 4: 7-26.

[63]

Scholz J. et al. Clinical pharmacokinetics of alfentanil, fentanil and sufentanil. An update // Clin. Pharmacokinet. 1996; 31: 275-292.

[64]

Servin F., Farinotti R., Haberer J., Desmonts J. Propofol infusion for maintence of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study // Anesthesiology. 1993; 78: 657-665.

[65]

Soderberg M., Thomson D., White T. Respiration, circulation, and anaesthetic management in obesity. Investigation before and after jejunoileal bypass // Acta Anaesth. Scand. 1977; 21: 55-61.

[66]

Stelfox H. et al. Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and strock volume // Crit. Care Med. 2006; 34: 1243-1246.

[67]

Stroh C., Hohmann U., Remmler K. Rhabdomyolysis after biliopancreatic diversion with duodenal switch // Obes. Surg. 2005; 15: 1347-1351.

[68]

Tsueda K. et al. Obesity supine death syndrome: reports of two morbidly obese patients // Anesth. Analg. 1979; 58: 345-347.

[69]

Ungern-Sternberg B., Regli A., Reber A., Schneider C. Effect of obesity and thoracic epidural analgesia on perioperative spirometry // Br. J. Anaesth. 2005; 94(1): 121-127.

[70]

Van Schakwyk L. et al. The incidence of difficult laryngoscopy in super-obese patients undergoing bariatric surgery. In: difficult airway society annual conference, Liverpool, UK, 2008.P. 28.

[71]

Vila P. et al. Acid aspiration prophilaxis in morbidly obese patients: famotidine vs ranitidine // Anaesthesia. 1991; 46: 967-999.

[72]

Virginia R. et al. Venous thromboembolism following bariatric surgery performed in bariatric centers of excellence: analysis of the bariatric outcomes longitudinal database // Surg. Obes. Relat. Dis. 2010; 6(35): S1-S26, PL-104.

[73]

Weaver S. et al. Routine awake fibre-optic intubation is not required for bariatric patients // Obes. Surg. 2010; 20(8).

[74]

Weingarten T. et al. Effects of CPAP on gastric pouch pressure after bariatric surgery // Obes. Surg. 2011; 21: 1900-1905.

[75]

Wool D. et al. Intraoperative fluid replacement and postoperative creatinephosphokinasae levels in laparoscopic bariatric patients // Obes. Surg. 2010; 20: 698-701.

[76]

Wulf H. Combined epidural with general anaesthesia vs. general anaesthesia alone-in major abdominal surgery. XXYI annual ESRA congress. Valencia, Spain, September 12-15, 2007; 238-239.

[77]

Zacchi P. et al. Effect of obesity on gastroesophageal resistence to flow in man // Dig. Dis. Sci. 1991; 36: 1473-1480.

[78]

Zhang C. The role of inflammatory cytokines in endothelial dysfunction // Basic. Res. Cardiol. 2008; 103: 398-406.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

70

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/